China IVF PGT-SR Chromosome Screening Cost Breakdown & Influencing Factors

PGT-SR chromosome screening costs vary significantly across different hospitals and cycles in China. This article, from a reproductive doctor's perspective, analyzes cost breakdown, influencing factors, expenditure differences across age groups, and common hidden fees to help patients rationally assess their budget.

China IVF PGT-SR Chromosome Screening Cost Breakdown & Influencing Factors
Surrogacy fees 2026-07-06

Opening: Real Consultation Scenario

Clinic Scenario A 33-year-old woman, with 4 spontaneous miscarriages. Couple's karyotype analysis revealed the male partner is a carrier of a balanced translocation between chromosomes 3 and 7. She asked: "Doctor, if we do third-generation IVF, how much will the PGT‑SR screening actually cost? How is each step charged?"

1. Direct Answer on PGT‑SR Costs

In reproductive centers in China that offer third-generation IVF (PGT), a complete cycle including ovarian stimulation, egg retrieval, blastocyst culture, PGT‑SR testing, and frozen embryo transfer typically costs between 90,000 – 180,000 RMB. The PGT‑SR test itself is charged per embryo, approximately 3,500 – 6,000 RMB per embryo. Most centers have a minimum charge (e.g., 30,000 – 50,000 RMB covering 8-10 embryos). If only PGT‑SR testing is performed without ovarian stimulation and egg retrieval (using existing frozen embryos), the cost reduces to 30,000 – 60,000 RMB.

2. Cost Breakdown

Cost Item Approximate Range (RMB) Description
Couple's Examinations & Genetic Counseling 3,000 – 8,000 Chromosome karyotype, gene panel, infectious diseases, fertility assessment, etc.
Ovarian Stimulation Medication + Monitoring 12,000 – 28,000 Varies greatly by age, ovarian response, and medication protocol.
Egg Retrieval Surgery + Anesthesia + Lab 10,000 – 18,000 Includes egg retrieval, egg processing, ICSI, etc.
Embryo Culture + Blastocyst Culture 8,000 – 15,000 Blastocyst culture, assisted hatching, etc.
PGT‑SR Testing (Core) 35,000 – 60,000 Charged per embryo, usually covers 8-10 embryos; excess embryos charged 3,500 – 6,000 each.
Embryo Freezing + Storage 3,000 – 6,000 / year Freezing fee + first year storage fee.
Frozen Embryo Transfer (including endometrial preparation) 8,000 – 15,000 Endometrial preparation, transfer procedure, luteal support.
Total (Complete Cycle) 90,000 – 180,000 Higher end for top-tier hospitals in first-tier cities; lower end for second-tier cities or some centers.

3. Cost Differences Between Hospitals

First-Tier City Top Hospitals (Beijing, Shanghai, Guangzhou)

Centers with early adoption of third-generation IVF mostly use NGS (Next-Generation Sequencing) or SNP array platforms for PGT‑SR, charging 4,500 – 6,000 RMB per embryo. Total cycle costs are typically 130,000 – 180,000 RMB. Some centers have a "testing fee cap" policy, e.g., a flat fee of 45,000 RMB for testing up to 10 embryos, with an additional 4,000 RMB per embryo beyond that.

Second-Tier Cities & Provincial Reproductive Centers

Testing fees are slightly lower, around 3,500 – 5,000 RMB per embryo, with total cycle costs of 90,000 – 140,000 RMB. However, note that some centers outsource PGT‑SR testing to third-party labs, which may incur additional logistics and service fees (approximately 2,000 – 4,000 RMB).

Private High-End Reproductive Centers

Environment and service fees constitute a higher proportion, with total cycle costs ranging from 160,000 – 250,000 RMB. However, some private centers bundle PGT‑SR testing fees into packages, suitable for patients who prefer transparent costs and fewer individual add-ons.

🔍 Practitioner's Insight: PGT‑SR testing fees can differ by over 30% between hospitals in the same city, but testing platforms (NGS vs SNP array) and data analysis depth vary. It is recommended to request a detailed fee breakdown during consultation, clarifying "whether the testing fee includes the biopsy procedure" and "how excess embryos are charged."

4. Key Factors Influencing Total PGT‑SR Costs

  • Number of Embryos: More eggs retrieved lead to more blastocysts and higher testing fees. However, most centers offer a "first-tier discount," making 8-10 embryos the most cost-effective.
  • Need for a New Stimulation Cycle: Starting from scratch vs. having existing frozen embryos results in a cost difference of 50,000 – 80,000 RMB.
  • Testing Technology Platform: NGS whole-genome low-depth sequencing and SNP array have slightly different costs; some centers use more efficient "breakpoint analysis" for PGT‑SR, which may increase costs by 10-15%.
  • Depth of Genetic Counseling: Some centers require separate genetic counseling for both partners (costing 800 – 2,000 RMB per session). If family verification is needed, additional testing of parents' or children's samples may be required.
  • Number of Transfers: If the first transfer is unsuccessful, subsequent frozen embryo transfers cost 10,000 – 18,000 RMB each (excluding testing fees).

5. Cost Differences Across Age Groups

Age Group Average Eggs Retrieved Approx. Blastocysts Formed Approx. PGT‑SR Testing Fee Approx. Total Cycle Cost
≤ 34 years 12–18 6–10 35,000 – 55,000 RMB 100,000 – 150,000 RMB
35–39 years 8–14 4–8 30,000 – 50,000 RMB 90,000 – 160,000 RMB
≥ 40 years 4–9 2–5 15,000 – 35,000 RMB 80,000 – 150,000 RMB

Older patients have fewer eggs and embryos, so the absolute testing fee is lower, but the "unit testing cost" per embryo is higher (due to the smaller number, making it harder to benefit from package discounts). Additionally, success rates are lower in older cycles, potentially requiring multiple cycles to accumulate embryos, with total expenditure possibly exceeding 200,000 RMB.

6. Most Easily Overlooked Details

  • Embryo Biopsy Fee: Some centers charge the biopsy procedure separately from the testing fee, costing approximately 2,000 – 4,000 RMB per procedure.
  • Embryo Cryopreservation Renewal Fee: The first year is usually included in the cycle fee; from the second year onwards, it costs 3,000 – 6,000 RMB annually. Long-term storage requires advance planning.
  • Additional Examinations for the Couple: Some centers require the male partner to undergo sperm chromosome structure analysis (FISH or karyotype), costing 1,500 – 3,000 RMB.
  • Supplementary Analysis for Inconclusive Results: Approximately 5-8% of embryos may require re-biopsy or additional testing due to DNA amplification failure or ambiguous results, incurring extra costs of 3,000 – 8,000 RMB.
  • Genetic Counseling Report Fee: Some centers charge a "report interpretation fee" of 500 – 1,500 RMB when issuing the final PGT‑SR report.

7. Most Common Pitfalls

  • Equating PGT‑A and PGT‑SR Costs: PGT‑SR testing is more complex than PGT‑A, typically costing 20-40% more.
    Reminder Clarify during consultation whether it is PGT‑A (screening for aneuploidy) or PGT‑SR (screening for structural rearrangements).
  • Ignoring "Testing Fee Per Embryo Without a Cap": If 15 blastocysts are formed, the testing fee could be as high as 70,000 – 90,000 RMB. It is advisable to ask in advance if there is a "cap price" or "excess discount."
  • Assuming Insurance Covers Most Costs: As of 2025, only a few regions in China (e.g., Beijing, Guangxi, Xinjiang) have included some assisted reproductive procedures in medical insurance, mostly for ovarian stimulation, egg retrieval, and transfer. PGT‑SR testing fees are "self-pay items" and are not yet covered.
  • Not Budgeting for the Risk of "No Normal Embryos": Carriers of balanced or Robertsonian translocations have a theoretical probability of obtaining normal/balanced embryos of about 25-30%. If no transferable embryo is obtained in a cycle, the initial investment (approximately 60,000 – 90,000 RMB) is non-refundable.
💡 Doctor's Perspective: It is recommended that before proceeding with PGT‑SR, couples complete their karyotype analysis and genetic counseling to clarify the translocation type and breakpoints, and then assess the expected proportion of transferable embryos. This helps determine the "cost-effectiveness of PGT‑SR" and avoid entering a cycle blindly.

8. Frequently Asked Questions

Q1: Which is more expensive, PGT‑SR or PGT‑A? PGT‑SR is usually 20-40% more expensive. PGT‑A only screens for numerical chromosomal abnormalities (aneuploidy), costing about 2,500 – 4,500 RMB per embryo. PGT‑SR requires analysis of chromosomal structural rearrangements (translocations, inversions, etc.), with more complex data interpretation, hence the higher cost.
Q2: Why is the PGT‑SR testing fee charged per embryo? Because the testing cost is mainly consumed in library construction, sequencing, and data analysis, each embryo is processed independently. If multiple embryos are tested simultaneously, the average cost decreases, which is why most centers offer a "first-tier package."
Q3: If there are no normal embryos this cycle, is the money wasted? Costs for stimulation, egg retrieval, blastocyst culture, and testing have already been incurred and are non-refundable. However, some centers may offer discounts for "untested embryos" or "unused stimulation medication," depending on the contract terms. It is advisable to fully assess the probability of obtaining a transferable embryo before starting the cycle.
Q4: For out-of-town patients coming to first-tier cities for PGT‑SR, how much extra is the total cost? Indirect costs such as transportation, accommodation, and lost work time amount to approximately 15,000 – 30,000 RMB (one cycle requires 3-5 round trips, each stay 2-5 days). Overall, out-of-town patients may spend 20-30% more than local patients.
Q5: Are there ways to reduce PGT‑SR costs? ① Choose a center with a "testing fee cap"; ② Use pre-testing (breakpoint mapping) to screen for clearly detectable embryos; ③ Accumulate 6-10 blastocysts before centralized testing to maximize package utilization; ④ Look into some centers' "research collaboration projects" or "clinical trials" that may waive part of the testing fee.

9. When is PGT‑SR Suitable / Unsuitable

Suitable Candidates for PGT‑SR

  • One or both partners are carriers of a balanced translocation or Robertsonian translocation
  • Chromosomal inversion (especially pericentric inversion associated with recurrent miscarriage)
  • History of multiple miscarriages (≥3) with confirmed chromosomal structural abnormality as a likely cause
  • Previous child born with a chromosomal structural abnormality (e.g., derivative chromosome)

Unsuitable Situations for PGT‑SR

  • Simple diminished ovarian reserve (AMH < 0.5 ng/mL) without chromosomal structural abnormality – PGT‑SR cannot improve embryo quantity
  • Recurrent miscarriage with normal karyotype for the couple, and other causes (immune, coagulation, anatomical, etc.) not ruled out
  • Advanced age (>42 years) with very poor ovarian response, often retrieving <3 eggs, may not yield enough embryos for testing
  • Contraindications for PGT‑SR testing (e.g., very poor embryo quality, complete inability to form blastocysts)

10. What to Prepare & How Long It Takes

  • Materials to Prepare: ID cards and marriage certificates for both partners, chromosome karyotype reports, genetic analysis reports of previous miscarriage tissue (if available), other fertility assessment reports (AMH, semen analysis, hysteroscopy, etc.).
  • Time Planning: From initial consultation to completion of transfer, it takes about 3-5 months. Ovarian stimulation and egg retrieval take about 2-3 weeks, blastocyst culture + PGT‑SR testing takes about 4-6 weeks, and frozen embryo transfer preparation takes about 2-4 weeks. If embryo accumulation or family verification is needed, the time may extend to 6-8 months.
  • Important Notes: Embryos need to be cryopreserved during testing. It is recommended to confirm the laboratory's cryopreservation qualifications and historical thaw survival rates.

11. What are the Risks

  • No Transferable Embryo: The probability of obtaining a normal/balanced embryo for balanced translocation carriers is about 25-30%, for Robertsonian translocation about 30-40%, and for inversion about 40-50%. A cycle may yield no embryo that passes testing.
  • Testing Failure or Inconclusive Results: About 3-5% of embryos may fail to produce a report due to DNA amplification failure or unclear analysis signals.
  • Embryo Biopsy Damage: The potential impact of blastocyst biopsy on the embryo is currently considered very low (<1% decrease in survival rate), but a theoretical risk remains.
  • Sunk Costs: If no transferable embryo is obtained, the initial investment cannot be recovered.

12. How to Judge and Choose

To determine if a center is suitable for PGT‑SR, evaluate it from three dimensions: ① Whether the genetic counseling team has experience interpreting chromosomal structural rearrangements; ② Whether the testing platform has breakpoint mapping capability (NGS + dedicated analysis workflow recommended); ③ Whether the pricing structure is transparent, especially "how excess embryos are charged" and "whether there is a discount policy if no normal embryos are obtained." It is advisable to consult at least 2-3 centers, compare fee schedules and success rate data before making a decision.

⚠️ Risk Reminder: PGT‑SR is a precise but expensive screening technology and cannot guarantee 100% healthy offspring. Cost is only part of the decision; it is more important to make a comprehensive judgment based on your own ovarian function, translocation type, and financial capacity. Do not blindly undergo stimulation just to "reach a certain number of embryos," nor choose a center lacking PGT‑SR capability or experience due to cost pressure. Before starting a cycle, be sure to develop an individualized plan together with your reproductive doctor and genetic counselor.
Reproductive Doctor 14 years of experience, specializing in third-generation IVF genetic counseling and PGT clinical decision-making Knowledge Base Content · Code REP‑PGT‑2025‑0312

Comments (0)

Leave a Comment